Angiotensin receptor-neprilysin inhibitor

Intervention1 paper1 finding

  • Humans1

Associations

1

Osteoporosis

downin humans1Low certainty

1 study

  1. Angiotensin receptor-neprilysin inhibitor lowers the risk of osteoporosis in humans (aHR 0.6, 95% CI 0.4-0.88).

    Humansin patients with heart failure, compared with ACEI2017 to 2022n = 12,808

    ARNI links to lower osteoporosis risk in heart failure · Internal and emergency medicine · 1 Oct 2026

Osteoporosis →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11
Internal and Emergency MedicineHumans

ARNI links to lower osteoporosis risk in heart failure

Patients taking an ARNI had an adjusted hazard ratio of 0.6 for osteoporosis compared with those taking an ACE inhibitor.Patients taking an ARNI had an adjusted hazard ratio of 0.6 for osteoporosis compared with those taking an ACE inhibitor.

Osteoporosis

Related